Summary
Elevance Health, Inc. (ELV), formerly Anthem, Inc., issued an 8-K filing on September 15, 2004, to announce that its officers would be meeting with securities analysts and investors from September 16 to September 28, 2004. The primary purpose of these meetings was to reaffirm the company's confidence in meeting the earnings expectations previously provided on July 27, 2004, through a press release and conference call. This communication serves as a Regulation FD disclosure, ensuring that all investors have access to the same information. While no new financial guidance was issued, the confirmation of existing earnings expectations is a positive signal to the market, suggesting that the company's performance is on track as previously communicated. Investors should note that this information is furnished and not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act.
Key Highlights
- 1Elevance Health (Anthem, Inc.) reaffirms its commitment to meeting previously issued earnings expectations.
- 2Company officers to engage in meetings with securities analysts and investors between September 16 and September 28, 2004.
- 3Earnings expectations were initially provided via press release and conference call on July 27, 2004.
- 4The filing is a Regulation FD disclosure, ensuring broad dissemination of information.
- 5No new financial guidance or material changes to outlook were announced in this filing.
- 6Information furnished is not considered 'filed' for liability purposes under Section 18 of the Securities Exchange Act.